根据名称进行药物检索

Motrin PM 与 Ziprasidone Injection

Motrin PM 与 Ziprasidone Injection互相作用以及同时服用的可能性。

检测结果:

Motrin PM <> Ziprasidone Injection

现实性: 23.07.2023 评论家: 医学副博士Shkutko P.M., in

在该服务的官方手册中，已注明相关研究结果统计规定的互相作用。该互相作用或对患者健康引起不良后果，或起到良好效果。具体联合用药问题，需遵从医嘱。

用户:

在使用之前酮，告诉医生，如果你还苯海拉明. 你可能需要的剂量调整或特别的测试，以便安全地使用这两种药物在一起。你应该通知你的医生如果你有迹象的膀胱的问题、口干、胃痛、发烧、视力模糊、混乱、头晕、或降低心率。你应该避免驱动直到你知道这些药物将影响你。重要的是要告诉你的医生关于所有其他药物的使用，包括维生素和草药。不停止使用药物而不首先说你的医生第一次。

医界专家:

监测中心作用的抗胆碱药可能引起的治疗作用的神经抑制剂。虽然这些药物已经用在一起的临床上的可能性的风险增加的不利影响，例如中央神经系统抑郁和迟发运动障碍，也应予以考虑。此外，过量的抗胆碱能影响可能会出现结合使用，这可能会导致瘫痪肠梗阻的、高热，热的行程，抗胆碱中毒综合症。周症状的抗胆碱醉通常包括瞳孔散大、视力模糊、冲洗脸、发烧、皮肤干燥和黏膜、心动过速、尿潴留，并便秘。中心的症状可能包括失忆迷失方向、不连贯、幻觉的精神病，谵妄、多动，抽搐或抽搐的运动，刻板和缉获量。在炎热的天气，风险高热和中暑应考虑，作为神经抑制剂可能会干扰调控温度在下丘脑虽然抗胆碱药剂倾向于抑制周汗机制。

管理：谨慎建议，如果抗胆碱的药剂的使用神经抑制剂，特别是在老年人和那些与基底的有机物大脑疾病，他们往往更加敏感，中央抗胆碱能影响这些药物和在人性中毒的症状可能很容易被忽视。预防性管理的抗胆碱的药剂，有时给予临床期间的精神病治疗药物引起的帕金森综合征或锥体外症状，但可能并不总是适当的。患者规定这种组合应该建议通知他们的医生及时如果他们遇到潜在的症状的抗胆碱醉如腹部疼痛、发烧、热不容忍行为，视力模糊、混乱、和幻觉。卧床病人应当建议避免活动需要精神的警觉直到他们知道如何使这些代理影响到他们。一剂用量减少一个或两个药物可能是必要的，如果过度的不良影响发展。在炎热的天气，患者应该避免长时间的太阳曝光和激烈的体力消耗并保持足够的流体摄入量。

来源

Hvizdos AJ, Bennett JA, Wells BG, Rappaport KB, Mendel SA "Anticholinergic psychosis in a patient receiving usual doses of haloperidol." Clin Pharm 2 (1983): 174-8
Rockland L, Cooper T, Schwartz F, Weber D, Sullivan T "Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics." Can J Psychiatry 35 (1990): 604-7
Zelman S, Guillan R "Heat stroke in phenothiazine-treated patients: a report of three fatalities." Am J Psychiatry 126 (1970): 1787-90
Kulik AV, Wilbur R "Delirium and stereotypy from anticholinergic antiparkinson drugs." Prog Neuropsychopharmacol Biol Psychiatry 6 (1982): 75-82
Byerly MJ, Christensen RC, Evans DL "Delirium associated with a combination of sertraline, haloperidol, and benztropine." Am J Psychiatry 153 (1996): 965-6
"Product Information. Cogentin (benztropine)." Merck & Co, Inc, West Point, PA.
Kwok JS, Chan TY "Recurrent heat-related illnesses during antipsychotic treatment." Ann Pharmacother 39 (2005): 1940-2
Hansen LB, Elley J, Christensen TR, Larsen NE, Naestoft J, Hvidberg EF "Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs." Br J Clin Pharmacol 7 (1979): 75-80
Sarnquist F, Larson CP Jr "Drug-induced heat stroke." Anesthesiology 39 (1973): 348-50
Forester D "Fatal drug-induced heat stroke." JACEP 7 (1978): 243-4
"Product Information. Artane (trihexyphenidyl)." Lederle Laboratories, Wayne, NJ.
Singh MM, Kay SR "Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia: implications for a neuropharmacological model." Neuropsychobiology 5 (1979): 74-86
Stadnyk AN, Glezos JD "Drug-induced heat stroke." Can Med Assoc J 128 (1983): 957-9
Johnson AL, Hollister LE, Berger PA "The anticholinergic intoxication syndrome: diagnosis and treatment." J Clin Psychiatry 42 (1981): 313-7
Moreau A, Jones BD, Banno V "Chronic central anticholinergic toxicity in manic depressive illness mimicking dementia." Can J Psychiatry 31 (1986): 339-41
Rivera-Calimlim L, Nasrallah H, Strauss J, Lasagna L "Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels." Am J Psychiatry 133 (1976): 646-52
Warnes H, Lehmann HE, Ban TA "Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases." Can Med Assoc J 96 (1967): 1112-3
Roth A, Akyol S, Nelson JC "Delirium associated with the combination of a neuroleptic, an SSRI, and benztropine." J Clin Psychiatry 55 (1994): 492-5
Mann SC, Boger WP "Psychotropic drugs, summer heat and humidity, and hyperplexia: a danger restated." Am J Psychiatry 135 (1978): 1097-100
Gershon S, Neubauer H, Sundland DM "Interaction between some anticholinergic agents and phenothiazines." Clin Pharmacol Ther 6 (1965): 749-56
Lee BS "Possibility of hyperpyrexia with antipsychotic and anticholinergic drugs." J Clin Psychiatry 47 (1986): 571